Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Number 10266594
US 10266594 B1Filled DateDec 7, 2018
Priority DateMay 15, 2012
Publication DateApr 4, 2019
Expiration DateMay 14, 2032
Inventor/ApplicantsAshok K. Gupta
Xi-Tao Wang
John P. Cogswell
Maria Jure-Kunkel
Stacie M. Goldberg
Jon M. Wigginton
Xi-Tao Wang
John P. Cogswell
Maria Jure-Kunkel
Stacie M. Goldberg
Jon M. Wigginton
ExaminesOUSPENSKI, ILIA I
Art Unit1644
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramSee the invalidated claims, subscribe to our Concierge Program.
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.